200 related articles for article (PubMed ID: 29290785)
1. Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies.
Cai X; Chen Z; Chen J; Ma X; Bai M; Wang T; Chen X; Wu D; Wei L; Li X; Lin Q; Wen J; Ruan D; Lin Z; Dong M; Wu X
J Cancer; 2018; 9(1):189-197. PubMed ID: 29290785
[No Abstract] [Full Text] [Related]
2. The Predictive Value of Albumin-to-Alkaline Phosphatase Ratio for Overall Survival of Hepatocellular Carcinoma Patients Treated with Trans-Catheter Arterial Chemoembolization Therapy.
Chen ZH; Zhang XP; Cai XR; Xie SD; Liu MM; Lin JX; Ma XK; Chen J; Lin Q; Dong M; Wu XY; Wen JY; Xu RH
J Cancer; 2018; 9(19):3467-3478. PubMed ID: 30310503
[No Abstract] [Full Text] [Related]
3. The prognostic value of the preoperative albumin to alkaline phosphatase ratio in patients with non-small cell lung cancer after surgery.
Zhang L; Zhang H; Yue D; Wei W; Chen Y; Zhao X; Zhu J; Zhang B; Zhang Z; Wang C
Thorac Cancer; 2019 Jul; 10(7):1581-1589. PubMed ID: 31161711
[TBL] [Abstract][Full Text] [Related]
4. Decreased albumin-to-alkaline phosphatase ratio predicted poor survival of resectable gastric cancer patients.
Wang Y; Xiong F; Yang J; Xia T; Jia Z; Shen J; Xu C; Feng J; Lu Y
J Gastrointest Oncol; 2021 Aug; 12(4):1338-1350. PubMed ID: 34532092
[TBL] [Abstract][Full Text] [Related]
5. Albumin-to-Alkaline Phosphatase Ratio is an Independent Prognostic Indicator in Combined Hepatocellular and Cholangiocarcinoma.
Zhang F; Lu S; Tian M; Hu K; Chen R; Zhang B; Ren Z; Shi Y; Yin X
J Cancer; 2020; 11(17):5177-5186. PubMed ID: 32742464
[No Abstract] [Full Text] [Related]
6. Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio in Hepatocellular Carcinoma Patients Treated with Liver Transplantation.
Li H; Wang L; Chen L; Zhao H; Cai J; Yao J; Zheng J; Yang Y; Wang G
J Cancer; 2020; 11(8):2171-2180. PubMed ID: 32127944
[No Abstract] [Full Text] [Related]
7. Prognostic impact of the pretreatment albumin to alkaline phosphatase ratio for nonmetastatic breast cancer patients.
Long ZQ; Hua X; Zhang WW; Lv SW; Deng JP; Guo L; He ZY; Lin HX
Cancer Manag Res; 2019; 11():4809-4814. PubMed ID: 31213902
[No Abstract] [Full Text] [Related]
8. Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy.
Cai XR; Chen ZH; Liu MM; Lin JX; Zhang XP; Chen J; Lin Q; Ma XK; Wen JY; Xie SD; Wu XY; Dong M
J Cancer; 2018; 9(13):2380-2388. PubMed ID: 30026834
[No Abstract] [Full Text] [Related]
9. Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio for
Gan Y; Ren J; Xian J; Yu H; Jin J; Li D; Li W
Int J Gen Med; 2022; 15():3405-3416. PubMed ID: 35378914
[TBL] [Abstract][Full Text] [Related]
10. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Significance Of Pretreatment Albumin/alkaline Phosphatase Ratio In Patients With Stage IB-IIA Cervical Cancer.
Zhang C; Li Y; Ji R; Zhang W; Zhang C; Dan Y; Qian H; He A
Onco Targets Ther; 2019; 12():9559-9568. PubMed ID: 32009792
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of combined pre- and postoperative albumin-to-alkaline phosphatase ratio for patients with hepatocellular carcinoma undergoing trans-catheter chemoembolisation.
Li J; Yang S; Li C; Zhu G; Xia J
Clin Radiol; 2023 Apr; 78(4):301-309. PubMed ID: 36690510
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer.
Li YT; Zhou XS; Han XM; Tian J; Qin Y; Zhang T; Liu JL
World J Gastrointest Oncol; 2022 May; 14(5):1002-1013. PubMed ID: 35646278
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of pretreatment albumin-to-alkaline phosphatase ratio in locally advanced laryngeal and hypopharyngeal cancer: Retrospective cohort study.
Wu J; You K; Jiang Y; Shen T; Song J; Chen C; Liu Y
J Cancer; 2021; 12(20):6182-6188. PubMed ID: 34539891
[No Abstract] [Full Text] [Related]
15. Albumin-to-alkaline phosphatase ratio: A novel prognostic index of overall survival in cholangiocarcinoma patients after surgery.
Xiong JP; Long JY; Xu WY; Bian J; Huang HC; Bai Y; Xu YY; Zhao HT; Lu X
World J Gastrointest Oncol; 2019 Jan; 11(1):39-47. PubMed ID: 30984349
[TBL] [Abstract][Full Text] [Related]
16. Albumin-to-Alkaline Phosphatase Ratio Associates with Good Prognosis of Hepatitis B Virus-Positive HCC Patients.
Li Q; Lyu Z; Wang L; Li F; Yang Z; Ren W
Onco Targets Ther; 2020; 13():2377-2384. PubMed ID: 32256088
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of the Albumin-to-Alkaline Phosphatase Ratio before Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma.
Yang L; Gao J; Zhou Y; Tao Z; He J; Yang J; Wang R; Zhang Y; Huang Y; Zhou L; Sun B
Chemotherapy; 2021; 66(1-2):40-46. PubMed ID: 33601377
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of Albumin-to-Alkaline Phosphatase Ratio in upper tract urothelial carcinoma.
Tan P; Xie N; Ai J; Xu H; Xu H; Liu L; Yang L; Wei Q
Sci Rep; 2018 Aug; 8(1):12311. PubMed ID: 30120312
[TBL] [Abstract][Full Text] [Related]
19. Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator for patients undergoing minimally invasive lung cancer surgery: Propensity score matching analysis using a prospective database.
Li SJ; Lv WY; Du H; Li YJ; Zhang WB; Che GW; Liu LX
Int J Surg; 2019 Sep; 69():32-42. PubMed ID: 31319230
[TBL] [Abstract][Full Text] [Related]
20. Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma.
Nie M; Sun P; Chen C; Bi X; Wang Y; Yang H; Liu P; Li Z; Xia Y; Jiang W
J Cancer; 2017; 8(5):809-815. PubMed ID: 28382143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
